Streetbeat News

Assets

VALE

A significant amount of unusual options activity has been observed for Vale (NYSE:VALE), with a majority of investors taking a bullish stance. Of the 20 strange trades detected, 70% were bullish and 30% were bearish. The total amount for puts was $899,749 and for calls was $369,906. Whales have been targeting a price range from $10.0 to $20.0 for Vale over the last 3 months. The price of VALE is currently up 2.64% at $13.2.

Portfolio Pulse from Benzinga Insights

October 10, 2023 | 8:30 pm

DVN

A significant bearish stance has been taken on Devon Energy (NYSE:DVN) by a large investor, as indicated by unusual options activity. The sentiment among these big-money traders is 90% bearish. Whales have been targeting a price range from $39.0 to $52.5 for Devon Energy over the last 3 months. The current price of DVN is $46.08. Analysts from Mizuho, Morgan Stanley, Citigroup, and UBS have maintained their ratings on Devon Energy with price targets ranging from $51 to $62.

Portfolio Pulse from Benzinga Insights

October 10, 2023 | 8:30 pm

VRTS

Virtus Investment Partners, Inc. (NASDAQ:VRTS) reported preliminary assets under management of $162.5 billion as of September 30, 2023, a decrease from June 30, 2023. The decrease is attributed to market depreciation and net outflows in open-end funds and institutional accounts, partially offset by net inflows in retail separate accounts. The company also provided services to $2.5 billion of other fee-earning assets, not included in assets under management.

Portfolio Pulse from Benzinga Newsdesk

October 10, 2023 | 8:24 pm

SANA

Sana Biotechnology has announced plans to reduce near-term spending on its Fusogen platform for in vivo gene delivery. This decision will postpone the planned Investigational New Drug (IND) application for SG299.

Portfolio Pulse from Benzinga Newsdesk

October 10, 2023 | 8:23 pm

LFCR

Lifecore Biomedical has provided an update on its delayed filings, anticipating to report its FY24 Q1 results in late October or early November, pending completion of its annual audit. The company has added two additional projects to its commercial development portfolio, increasing its development opportunity pipeline by 14 to 58. Lifecore is also working on completing its Annual Report on Form 10-K for the fiscal year ended May 28, 2023, which has been delayed due to accounting for certain recent non-routine corporate transactions.

Portfolio Pulse from Benzinga Newsdesk

October 10, 2023 | 8:21 pm

EFHT

EF Hutton Acquisition Corporation I has entered into a definitive securities purchase agreement with an institutional investor for the issuance of a senior secured convertible note with a principal amount of $15,819,209.

Portfolio Pulse from Bill Haddad

October 10, 2023 | 8:16 pm

LUNG

Pulmonx's CFO, Derrick Sung, has stepped down from his position. John McKune has been appointed as the interim CFO.

Portfolio Pulse from Bill Haddad

October 10, 2023 | 8:10 pm

JNJ

Unusual options activity has been observed for Johnson & Johnson (NYSE:JNJ), with a bearish stance taken by a large investor. The sentiment among these big-money traders is split between 40% bullish and 60% bearish. The whales have been targeting a price range from $135.0 to $180.0 for Johnson & Johnson over the last 3 months. RBC Capital and Cantor Fitzgerald have downgraded their actions on JNJ, with price targets of $178 and $215 respectively.

Portfolio Pulse from Benzinga Insights

October 10, 2023 | 8:00 pm

SCHW

A significant bearish stance has been taken on Charles Schwab (NYSE:SCHW) as indicated by unusual options activity. The sentiment among these big-money traders is split between 32% bullish and 67% bearish. The whales have been targeting a price range from $27.5 to $77.5 for Charles Schwab over the last 3 months. The current price of SCHW is $51.86, up 0.21%. Analysts from Piper Sandler, Barclays, JMP Securities, and Raymond James have maintained their ratings on Charles Schwab with price targets ranging from $55 to $77.

Portfolio Pulse from Benzinga Insights

October 10, 2023 | 8:00 pm

TFC

Truist Financial is reportedly in talks to sell its insurance business, leading to a rise in its share prices.

Portfolio Pulse from Bill Haddad

October 10, 2023 | 7:56 pm